Vosevi (sofosbuvir/velpatasvir/voxilaprevir)

pCPA File Number: 21009
Negotiation Status:
Concluded with an LOI
Indication(s):
Chronic Hepatitis C
Sponsor/Manufacturer:
Gilead Sciences Canada Inc.
CDA-AMC Project Number:
SR0529-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: